HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norwood Procedure for Palliation of Hypoplastic Left Heart Syndrome: Right Ventricle to Pulmonary Artery Conduit vs Modified Blalock-Taussig Shunt.

Abstract
Patients with hypoplastic left heart syndrome undergo a series of operations to separate the pulmonary and systemic circulations. The first of at least 3 operations occurs in the newborn period, with a stage I palliation. The goal of stage I palliation is to provide pulmonary blood flow and create an unobstructed systemic outflow tract. Advances in surgical techniques and intraoperative and postoperative care have helped decrease morbidity and mortality for patients with hypoplastic left heart syndrome who have the stage I Norwood operation, but the patients continue to be at increased risk for hemodynamic collapse and adverse outcomes. This article discusses risk factors, surgical approach, postoperative nursing and medical management strategies, differences between and outcomes for the Norwood operation with the right ventricle to pulmonary artery conduit and the Norwood operation with a modified Blalock-Taussig shunt.
AuthorsDorothy M Beke
JournalCritical care nurse (Crit Care Nurse) Vol. 36 Issue 6 Pg. 42-51 (Dec 2016) ISSN: 1940-8250 [Electronic] United States
PMID27908945 (Publication Type: Comparative Study, Journal Article, Review)
Copyright©2016 American Association of Critical-Care Nurses.
Topics
  • Blalock-Taussig Procedure (methods, mortality)
  • Female
  • Follow-Up Studies
  • Heart Transplantation (methods)
  • Hemodynamics (physiology)
  • Humans
  • Hypoplastic Left Heart Syndrome (diagnosis, mortality, surgery)
  • Infant
  • Infant, Newborn
  • Male
  • Norwood Procedures (methods, mortality)
  • Palliative Care (methods)
  • Postoperative Care (methods)
  • Survival Analysis
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: